Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection
The prevalence of potential DDI risk after withdrawal of nirmatlevir-ritonavir was high and should be given more attention.
Authors
- Yoon Dae Han (ORCID: https://orcid.org/0000-0002-2136-3578)
- Lingyan Yu (ORCID: https://orcid.org/0000-0001-7828-139X)
- Yi Gou (ORCID: https://orcid.org/0000-0002-2900-4983)
- Zhenwei Yu (ORCID: https://orcid.org/0000-0002-3776-2290)
- Yuhua Zhao
- Jieqiong Liu (ORCID: https://orcid.org/0000-0002-5171-6960)
Institutions
- Sir Run Run Shaw Hospital (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.jgar.2024.12.014
- Citations
- 3
- Primary Topic
- Hematological disorders and diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.07